Fischer Medical Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2025 ,inter alia, to consider and approve audited financial ....
FISCHER · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fischer Medical Ventures Ltd has informed BSE that its Board of Directors will meet on May 28, 2025 via video conferencing. The meeting will consider and approve the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2025. The Board will also consider recommending a dividend, if any, for FY25. The trading window for insiders is already closed and will remain so until 48 hours after the results are declared.
This is a routine pre-results intimation and carries no immediate price action. Investors should watch May 28 for actual numbers and any dividend announcement, which will be the first meaningful catalyst.